Since CSCs contribute to the aggressive nature of tumours and BLBP was a marker for these CSCs in ependymoma, we proposed that BLBP expression could be of robust prognostic value in ependymoma, a tumour for which prognostic markers are urgently required. This evidence concerns the gene FABP7 and neoplasm.